Drug Shortage Report for KAYEXALATE

Last updated on 2019-02-06 History
Report ID 72245
Drug Identification Number 02026961
Brand name KAYEXALATE
Common or Proper name Kayexelate
Company Name SANOFI-AVENTIS CANADA INC
Active Ingredient(s) SODIUM POLYSTYRENE SULFONATE
Strength(s) 100%
Dosage form(s) POWDER
Route of administration ORAL RECTAL
Packaging size 454g
ATC code V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-01-14
Actual start date
Estimated end date 2019-02-08
Actual end date 2019-02-05
Shortage status Resolved
Updated date 2019-02-06
Company comments
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-02-06 English Compare
v6 2019-02-05 French Compare
v5 2019-02-05 English Compare
v4 2019-01-30 French Compare
v3 2019-01-30 English Compare
v2 2019-01-15 French Compare
v1 2019-01-15 English Compare